Korea to approve AstraZeneca's COVID-19 drug Evusheld this month
A worker packages AstraZeneca's Evusheld COVID-19 medication in this screen grab from undated video provided by the company in December 2021. AP-Yonhap
Korea is pushing to approve AstraZeneca's antibody treatment Evusheld this month to better protect people with weak immune systems from COVID-19, the health authorities said Wednesday.
The government plans to wrap up due procedures for its approval for emergency use within June and administer it to the people "as soon as possible," Second Health Vice Minister Lee Gi-il said during a meeting of the Central Disaster and Safety Countermeasures Headquarters.
Evusheld is designed to stop the coronavirus from infecting people with compromised immune systems, and other high-risk groups. (Yonhap)